TrialEBioMedicine2024

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a two-year follow-up of the prospective clinical trial COVAXID.

Puran Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.